Aardvark Therapeutics, Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-100.0% -$717K
$0
R&D↑+77.4% +$6M
$14M
D&A↑+25.0% +$2K
$10K
Operating Income↓-247.7% -$13M
$-18M
EBITDA↑+25.0% +$2K
$10K
Net Income↓-290.1% -$12M
$-16M
Operating Margin
-509.1%
Net Margin
-418.2%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+0.0pts
0.2%
Revenue YoY Variation
-100.0%
Income YoY Variation
-247.7%
Revenue QoQ Variation
-100.0%
Income QoQ Variation↓-27.9pts
-11.7%